Literature DB >> 22661518

Interleukin-18: the master regulator driving destructive and remodeling processes in the lungs of patients with chronic obstructive pulmonary disease?

Takahiro Nakajima, Caroline A Owen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22661518      PMCID： PMC3373072          DOI： 10.1164/rccm.201204-0590ED

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  19 in total

1.  Neutralizing antibodies to IL-18 ameliorate experimental autoimmune neuritis by counter-regulation of autoreactive Th1 responses to peripheral myelin antigen.

Authors:  Shuo Yu; Zhiguo Chen; Eilhard Mix; Shun-Wei Zhu; Bengt Winblad; Hans-Gustaf Ljunggren; Jie Zhu
Journal:  J Neuropathol Exp Neurol       Date:  2002-07       Impact factor: 3.685

2.  Cytokine production by bronchoalveolar lavage T lymphocytes in chronic obstructive pulmonary disease.

Authors:  Adam Barczyk; Władysław Pierzchała; Onn M Kon; Borja Cosio; Ian M Adcock; Peter J Barnes
Journal:  J Allergy Clin Immunol       Date:  2006-04-03       Impact factor: 10.793

3.  IL-18 improves the early antimicrobial host response to pneumococcal pneumonia.

Authors:  Fanny N Lauw; Judith Branger; Sandrine Florquin; Peter Speelman; Sander J H van Deventer; Shizuo Akira; Tom van der Poll
Journal:  J Immunol       Date:  2002-01-01       Impact factor: 5.422

4.  Therapeutic effect of neutralizing endogenous IL-18 activity in the collagen-induced model of arthritis.

Authors:  C Plater-Zyberk; L A Joosten; M M Helsen; P Sattonnet-Roche; C Siegfried; S Alouani; F A van De Loo; P Graber; S Aloni; R Cirillo; E Lubberts; C A Dinarello; W B van Den Berg; Y Chvatchko
Journal:  J Clin Invest       Date:  2001-12       Impact factor: 14.808

5.  Synergistic inhibition of tumor growth in a murine mammary adenocarcinoma model by combinational gene therapy using IL-12, pro-IL-18, and IL-1beta converting enzyme cDNA.

Authors:  K Oshikawa; F Shi; A L Rakhmilevich; P M Sondel; D M Mahvi; N S Yang
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-09       Impact factor: 11.205

6.  IL-18 is induced and IL-18 receptor alpha plays a critical role in the pathogenesis of cigarette smoke-induced pulmonary emphysema and inflammation.

Authors:  Min-Jong Kang; Robert J Homer; Amy Gallo; Chun Geun Lee; Kristina A Crothers; Soo Jung Cho; Carolyn Rochester; Hilary Cain; Geoffrey Chupp; Ho Joo Yoon; Jack A Elias
Journal:  J Immunol       Date:  2007-02-01       Impact factor: 5.422

7.  Interleukin-18 production and pulmonary function in COPD.

Authors:  H Imaoka; T Hoshino; S Takei; T Kinoshita; M Okamoto; T Kawayama; S Kato; H Iwasaki; K Watanabe; H Aizawa
Journal:  Eur Respir J       Date:  2007-11-07       Impact factor: 16.671

8.  The nature of small-airway obstruction in chronic obstructive pulmonary disease.

Authors:  James C Hogg; Fanny Chu; Soraya Utokaparch; Ryan Woods; W Mark Elliott; Liliana Buzatu; Ruben M Cherniack; Robert M Rogers; Frank C Sciurba; Harvey O Coxson; Peter D Paré
Journal:  N Engl J Med       Date:  2004-06-24       Impact factor: 91.245

Review 9.  Pulmonary vascular involvement in chronic obstructive pulmonary disease.

Authors:  N F Voelkel; C D Cool
Journal:  Eur Respir J Suppl       Date:  2003-11

10.  IL-18 gene therapy develops Th1-type immune responses in Leishmania major-infected BALB/c mice: is the effect mediated by the CpG signaling TLR9?

Authors:  Y Li; K Ishii; H Hisaeda; S Hamano; M Zhang; K Nakanishi; T Yoshimoto; H Hemmi; K Takeda; S Akira; Y Iwakura; K Himeno
Journal:  Gene Ther       Date:  2004-06       Impact factor: 5.250
View more
  9 in total

Review 1.  Synergy of Interleukin (IL)-5 and IL-18 in eosinophil mediated pathogenesis of allergic diseases.

Authors:  Hemanth Kumar Kandikattu; Sathisha Upparahalli Venkateshaiah; Anil Mishra
Journal:  Cytokine Growth Factor Rev       Date:  2019-05-10       Impact factor: 7.638

2.  IL-18 and related function proteins associated with tuberculosis severity and screening for active TB among patients with non-mycobacterial community-acquired pneumonia (CAP).

Authors:  Sebastian Wawrocki; Michal Seweryn; Grzegorz Kielnierowski; Wieslawa Rudnicka; Magdalena Druszczynska
Journal:  Saudi J Biol Sci       Date:  2020-09-08       Impact factor: 4.219

3.  Myeloid differentiation factor 88-dependent signaling is critical for acute organic dust-induced airway inflammation in mice.

Authors:  Christopher Bauer; Tammy Kielian; Todd A Wyatt; Debra J Romberger; William W West; Angela M Gleason; Jill A Poole
Journal:  Am J Respir Cell Mol Biol       Date:  2013-06       Impact factor: 6.914

4.  A comprehensive pathway map of IL-18-mediated signalling.

Authors:  D A B Rex; Nupur Agarwal; T S Keshava Prasad; Richard K Kandasamy; Yashwanth Subbannayya; Sneha M Pinto
Journal:  J Cell Commun Signal       Date:  2019-12-20       Impact factor: 5.782

Review 5.  Emerging pharmaceutical therapies for COPD.

Authors:  Sowmya P Lakshmi; Aravind T Reddy; Raju C Reddy
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-07-21

6.  N-Acetylcysteine (NAC) Inhibits Synthesis of IL-18 in Macrophage by Suppressing NLRP3 Expression to Reduce the Production of IFN-γ from NK Cells.

Authors:  Xiaopeng Liu; Xufeng Lu; Zhixiong Hu
Journal:  Comput Math Methods Med       Date:  2021-12-03       Impact factor: 2.238

7.  Pathways linked to unresolved inflammation and airway remodelling characterize the transcriptome in two independent severe asthma cohorts.

Authors:  Stephany Sánchez-Ovando; Stelios Pavlidis; Nazanin Zounemat Kermani; Katherine Joanne Baines; Daniel Barker; Peter G Gibson; Lisa G Wood; Ian M Adcock; Kian Fan Chung; Jodie Louise Simpson; Peter A B Wark
Journal:  Respirology       Date:  2022-06-07       Impact factor: 6.175

8.  Comparative transcriptomics in human COPD reveals dysregulated genes uniquely expressed in ferrets.

Authors:  Shah S Hussain; Yvonne J K Edwards; Emily Falk Libby; Denise Stanford; Stephen A Byzek; Don D Sin; Merry-Lynn McDonald; S Vamsee Raju; Steven M Rowe
Journal:  Respir Res       Date:  2022-10-10

Review 9.  Cytokine inhibition in the treatment of COPD.

Authors:  Gaetano Caramori; Ian M Adcock; Antonino Di Stefano; Kian Fan Chung
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2014-04-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.